Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): Study of inflammatory cells and transforming growth factor β1 expression in affected skin

Arthritis and Rheumatism

Volumn 50, Issue 8, 2004, Pages 2660-2666

  Jiménez, Sergio A ^a   Artlett, Carol M ^a   Sandorfi, Nora ^a   Derk, Chris ^a   Latinis, Kevin ^b   Sawaya, Heloisa ^a   Haddad, Richard ^c   Shanahan, Joseph C ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; BLOOD CLOTTING FACTOR 13A; C REACTIVE PROTEIN; CARBON MONOXIDE; CHLORDANE; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DIALYSIS; ERYTHROCYTE SEDIMENTATION RATE; FASCIA; FASCIITIS; FEMALE; FLEXION CONTRACTURE; HEART MUSCLE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; KIDNEY FAILURE; LUNG; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; NEPHROGENIC FIBROSING DERMOPATHY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SKELETAL MUSCLE; SKIN DISEASE; SKIN FIBROSIS; SUBCUTANEOUS TISSUE; SYSTEMIC SCLEROSIS;

ADULT; AGED; FASCIA; FEMALE; FIBROSIS; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; KIDNEY FAILURE, CHRONIC; LUNG; MALE; MIDDLE AGED; MUSCLES; MYOCARDIUM; RENAL DIALYSIS; SKIN; SKIN DISEASES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 4043086401     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20362     Document Type: Article

References (11)

1. Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE. Scleromyxoedema-like cutaneous disease in renal-dialysis patients. Lancet 2000;356:1000-1.
2. Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001;23:383-93.
3. Cowper SE. Nephrogenic fibrosing dermopathy: the first 6 years. Curr Opin Rheumatol 2003;15:785-90.
4. Swartz RD, Crofford LJ, Phan SH, Ike RW, Su LD. Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure. Am J Med 2003;114:563-72.
5. Ting WW, Stone MS, Madison KC, Kurtz K. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 2003;139:903-6.
6. Sackner MA. Scleroderma. In: Modern medical monographs. New York: Grune & Stratton; 1966. p. 81.
7. Young RH, Mark GJ. Pulmonary vascular changes in scleroderma. Am J Med 1978;64:998-1004.
8. Rodenberg RJ, Raats JM, Pruijn GJ, van Venrooij WJ. Cell death: a trigger of autoimmunity? Bioessays 2000;22:627-36.
9. Gruschwitz MS, Hornstein OP. Expression of transforming growth factor type β on human epidermal dendritic cells. J Invest Dermatol 1992;99:114-6.
10. Strobl H, Knapp W. TGF-β1 regulation of dendritic cells. Microbes Infect 1999;1:1283-90.
11. Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O. Transforming growth factor β1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 1998;187:961-6.